Altimmune (ALT) Enterprise Value Growth (3y) (2013 - 2026)
Altimmune (ALT) Enterprise Value Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.83% |
| Dec 31, 2025 | 26.66% |
| Sep 30, 2025 | 32.79% |
| Jun 30, 2025 | 0.29% |
| Mar 31, 2025 | 35.11% |
| Dec 31, 2024 | 42.07% |
| Sep 30, 2024 | 11.32% |
| Jun 30, 2024 | 35.96% |
| Mar 31, 2024 | 7.03% |
| Dec 31, 2023 | 14.45% |
| Sep 30, 2023 | 25.09% |
| Jun 30, 2023 | -8.47% |
| Mar 31, 2023 | -109.80% |
| Dec 31, 2022 | -43.94% |
| Sep 30, 2022 | -163.44% |
| Jun 30, 2022 | -64.20% |
| Mar 31, 2022 | -58.08% |
| Dec 31, 2021 | -75.88% |
| Sep 30, 2021 | -191.97% |
| Jun 30, 2021 | -243.95% |